The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study

Hasan Ali BarmanBarış İkitimurBurçak Kılıçkıran AvcıEser DurmazAdem AtıcıSerkan AslanSerdar CeylanerHakan Karpuz

Published in: Balkan medical journal (2019)

Fabry disease should be considered in the differential diagnosis in a highly selected patient population with unexplained left ventricular hypertrophy. The cardiologist may play an important role in the screening and diagnosis of the disease.

Keyphrases

hypertrophic cardiomyopathy
left ventricular
replacement therapy
risk factors
mitral valve
acute coronary syndrome
cardiac resynchronization therapy